Record Information |
---|
Version | 2.0 |
---|
Created at | 2021-01-05 21:49:23 UTC |
---|
Updated at | 2021-07-15 17:11:46 UTC |
---|
NP-MRD ID | NP0012444 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Silybin B |
---|
Provided By | NPAtlas |
---|
Description | Silybin B is found in Anastatica hierochuntica and Aspergillus iizukae. Silybin B was first documented in 2014 (PMID: 24456525). Based on a literature review very few articles have been published on (2R,3R)-3,5,7-trihydroxy-2-[(2S,3S)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-3,4-dihydro-2H-1-benzopyran-4-one (PMID: 34318464) (PMID: 34198653) (PMID: 33706132) (PMID: 33553948). |
---|
Structure | [H]OC1=C([H])C(O[H])=C2C(O[C@]([H])(C3=C([H])C([H])=C4O[C@@]([H])(C([H])([H])O[H])[C@@]([H])(OC4=C3[H])C3=C([H])C([H])=C(O[H])C(OC([H])([H])[H])=C3[H])[C@@]([H])(O[H])C2=O)=C1[H] InChI=1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20-,23-,24-,25+/m0/s1 |
---|
Synonyms | Value | Source |
---|
2,3-Dehydrosilybin | MeSH | Hepa loges | MeSH | Hepa-merz sil | MeSH | Hepar pasc | MeSH | Silibinin a | MeSH | Silibinin | MeSH | Silybin a | MeSH | Silybinin | MeSH | Ardeyhepan | MeSH | Silibinin b | MeSH | Durasilymarin | MeSH | Legalon forte | MeSH | Silibin | MeSH | Alepa-forte | MeSH | Hepa merz sil | MeSH | HepaBesch | MeSH | Hepar-pasc | MeSH | Heplant | MeSH | 2,3 Dehydrosilybin | MeSH | Alepa forte | MeSH | Cefasilymarin | MeSH | Heparsyx | MeSH | Lagosa | MeSH | Hepa-loges | MeSH | Silybin | MeSH |
|
---|
Chemical Formula | C25H22O10 |
---|
Average Mass | 482.4410 Da |
---|
Monoisotopic Mass | 482.12130 Da |
---|
IUPAC Name | (2R,3R)-3,5,7-trihydroxy-2-[(2S,3S)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-3,4-dihydro-2H-1-benzopyran-4-one |
---|
Traditional Name | (2R,3R)-3,5,7-trihydroxy-2-[(2S,3S)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydro-1-benzopyran-4-one |
---|
CAS Registry Number | Not Available |
---|
SMILES | COC1=C(O)C=CC(=C1)[C@@H]1OC2=C(O[C@H]1CO)C=CC(=C2)[C@H]1OC2=CC(O)=CC(O)=C2C(=O)[C@@H]1O |
---|
InChI Identifier | InChI=1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20-,23-,24-,25+/m0/s1 |
---|
InChI Key | SEBFKMXJBCUCAI-WAABAYLZSA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Classification | Not classified |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - El-Elimat T, Raja HA, Graf TN, Faeth SH, Cech NB, Oberlies NH: Flavonolignans from Aspergillus iizukae, a fungal endophyte of milk thistle (Silybum marianum). J Nat Prod. 2014 Feb 28;77(2):193-9. doi: 10.1021/np400955q. Epub 2014 Jan 23. [PubMed:24456525 ]
- Islam A, Mishra A, Siddiqui MA, Siddiquie S: Recapitulation of Evidence of Phytochemical, Pharmacokinetic and Biomedical Application of Silybin. Drug Res (Stuttg). 2021 Jul 27. doi: 10.1055/a-1528-2721. [PubMed:34318464 ]
- Vrba J, Papouskova B, Lnenickova K, Kosina P, Kren V, Ulrichova J: Metabolism of 2,3-Dehydrosilybin A and 2,3-Dehydrosilybin B: A Study with Human Hepatocytes and Recombinant UDP-Glucuronosyltransferases and Sulfotransferases. Antioxidants (Basel). 2021 Jun 14;10(6). pii: antiox10060954. doi: 10.3390/antiox10060954. [PubMed:34198653 ]
- Faisal Z, Mohos V, Fliszar-Nyul E, Valentova K, Kanova K, Lemli B, Kunsagi-Mate S, Poor M: Interaction of silymarin components and their sulfate metabolites with human serum albumin and cytochrome P450 (2C9, 2C19, 2D6, and 3A4) enzymes. Biomed Pharmacother. 2021 Jun;138:111459. doi: 10.1016/j.biopha.2021.111459. Epub 2021 Mar 9. [PubMed:33706132 ]
- Chen X, Deng X, Han X, Liang Y, Meng Z, Liu R, Su W, Zhu H, Fu T: Inhibition of Lysozyme Amyloid Fibrillation by Silybin Diastereoisomers: The Effects of Stereochemistry. ACS Omega. 2021 Jan 20;6(4):3307-3318. doi: 10.1021/acsomega.0c05788. eCollection 2021 Feb 2. [PubMed:33553948 ]
|
---|